KDM8 and hepatocellular carcinoma: A Kaplan-Meier survival analysis exhibited that HCC patients with low JMJD5 expression had shorter survival time compared with those with high JMJD5 expression (P < 0.01) (Figure 1C), and the median survival of HCC patients with low JMJD5 expression and high JMJD5 expression was 987 and 2141 days respectively.